Normal Fasting Insulin Levels in Children
While measuring fasting insulin levels in children has limited clinical utility due to lack of standardization, the most commonly cited reference range from guideline literature suggests normal fasting insulin is <15 mU/L (or <15 µIU/mL), borderline high is 15-20 mU/L, and high is >20 mU/L 1.
Important Clinical Context
Why Insulin Measurement Has Limited Value
Routine measurement of fasting insulin levels is NOT recommended for clinical decision-making in children 2. The 2017 Endocrine Society Clinical Practice Guideline explicitly states that measuring plasma insulin concentrations "has no diagnostic value" in clinical settings for several critical reasons:
- No standardized assays: Different laboratories use different methods with poor reproducibility 2
- Massive overlap: Fasting insulin shows considerable overlap between insulin-resistant and insulin-sensitive children, making it impossible to reliably distinguish normal from abnormal 2
- No validated cutoffs: Proposed cutoff values vary by 2.5-fold across different studies 2
- Pubertal confounding: Transient physiological insulin resistance during puberty further complicates interpretation 2
- Race/ethnicity differences: Insulin concentrations differ due to variations in metabolic clearance rates 2
Age and Sex-Specific Reference Values from Research
Despite guideline recommendations against routine use, research studies provide population-based reference data:
Prepubertal Children
- Ages <7.5 years: Median ~2.9 µIU/mL (range: 1.3-10.9) 3
- Ages >7.5 years: Median ~5.0 µIU/mL (range: 1.7-9.6) 3
- European cohort (3-11 years): Median ranges from 17.4 pmol/L (
2.5 µIU/mL) at age 3 to 53.5 pmol/L (7.6 µIU/mL) at age 10-11 in girls 4
Pubertal Children
Suggested Upper Limits (Research-Based)
What to Do Instead
Focus on glucose metabolism markers that have clinical utility:
Fasting plasma glucose - The primary screening tool recommended for at-risk children 1:
- Screen children who are overweight with ≥2 additional risk factors
- Risk factors: family history of type 2 diabetes, high-risk race/ethnicity, signs of insulin resistance (acanthosis nigricans), hypertension, dyslipidemia
Oral glucose tolerance test - Most effective screening method for dysglycemia (100% effectiveness at $390 per case identified) 2
HbA1c - Least effective screening method (7-32% effectiveness, $938-$3370 per case) 2
Critical Pitfalls to Avoid
- Do not use insulin levels to diagnose insulin resistance - They cannot distinguish between normal glucose tolerance and impaired glucose tolerance in obese youth 2
- Do not use insulin levels to screen for diabetes risk - Fasting insulin is similar in obese youth with normal versus impaired glucose tolerance 2
- Do not rely on HOMA-IR clinically - While research uses HOMA-IR >2.0 (prepubertal) or >2.6 (pubertal) as concerning 3, this remains a research tool without clinical validation
When Insulin Measurement May Be Considered
The only guideline-supported context is as "a reasonable clinical alternative for evaluating insulin resistance" when the gold standard (euglycemic insulin clamp) is unavailable, using the ranges: normal <15 mU/L, borderline 15-20 mU/L, high >20 mU/L 1. However, even this is qualified as "less accurate" and should not replace clinical assessment and glucose-based screening.